Sign In
Buy BCDA
$0.82
+0.0531 (+6.89%)
At Close: Jul 31, 2026
Does BioCardia, Inc.'s (NASDAQ:BCDA) CEO Pay Compare Well With Peers?
11:30am, Thursday, 13'th Feb 2020
In 2002 Peter Altman was appointed CEO of BioCardia, Inc. (NASDAQ:BCDA). First, this article will compare CEO...
Contrasting Audentes Therapeutics (NASDAQ:BOLD) and BioCardia (NASDAQ:BCDA)
07:28am, Tuesday, 28'th Jan 2020
Audentes Therapeutics (NASDAQ:BOLD) and BioCardia (OTCMKTS:BCDA) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institution
Tech Majors, Boeing, UPS And Tesla On Tap
11:38am, Saturday, 25'th Jan 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Key events next week - healthcare
01:16pm, Friday, 24'th Jan 2020
Noteworthy events during the week of January 26 - February 1 for healthcare investors.MONDAY (1/27): European Medicines Agency advisory group CHMP monthly agenda due.TUESDAY (1/28): ASM Biothreats Con
Biocardia Announces FDA Clearance for Morph DNA Deflectable Guide Catheter
01:00pm, Tuesday, 14'th Jan 2020
SAN CARLOS, Calif., Jan. 14, 2020 -- BioCardia®, Inc. , a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today.
BioCardia®, Inc. [NASDAQ: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the issuance of three new patents for the company�
Will BioCardia (NASDAQ:BCDA) Spend Its Cash Wisely?
03:40pm, Monday, 30'th Dec 2019
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
BioCardia Reports 2019 Third Quarter Financial Results and Business Highlights
10:24pm, Tuesday, 19'th Nov 2019
SAN CARLOS, Calif., Nov. 19, 2019 -- BioCardia®, Inc. , a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today.
Investors Who Bought BioCardia (NASDAQ:BCDA) Shares A Year Ago Are Now Down 80%
12:44pm, Monday, 11'th Nov 2019
BioCardia, Inc. (NASDAQ:BCDA) shareholders should be happy to see the share price up 21% in the last month. But that...
BioCardia to Present at Dawson James Securities 5th Annual Small Cap Growth Conference
12:00pm, Monday, 28'th Oct 2019
SAN CARLOS, Calif., Oct. 28, 2019 -- BioCardia®, Inc. (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today.
BioCardia Receives CE Mark Renewal For Helix Biotherapeutic Delivery Catheter And Morph Guide Catheter Through May 2024
12:00pm, Tuesday, 08'th Oct 2019
SAN CARLOS, Calif., Oct. 08, 2019 -- BioCardia (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced.
BioCardia Announces the Appointment of Two New Board Members
12:00pm, Wednesday, 02'nd Oct 2019
BioCardia (BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the appointment of experienced CEOs Jim Allen and Andrew Blank to it
SAN CARLOS, Calif., Oct. 01, 2019 -- BioCardia (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced.
